Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The FDA approved a new Pfizer drug for hair loss in teens.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

5-ARI therapy may help prevent prostate cancer progression.

uPA helps hair follicle cells grow.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

RORA may help regulate hair growth by affecting hair follicle stem cells.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.